Anson Funds Management’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-122,650
Closed -$4.83M – 194
2023
Q2
$4.83M Buy
+122,650
New +$4.33M 0.8% 26

Anson Funds Management's ISEE Position: Q3 2023 in Review

Anson Funds Management sold out of IVERIC bio (ISEE) in Q3 2023, closing a stake of 122,650 shares — an estimated $4.83M sold.

Anson Funds Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $4.83M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Anson Funds Management reported no remaining IVERIC bio position as of Q3 2023 after selling out during the quarter.
  • Anson Funds Management sold 122,650 IVERIC bio shares in Q3 2023, an estimated $4.83M.
  • Anson Funds Management first reported a position in IVERIC bio in Q2 2023 and held it in 1 quarter.
  • Anson Funds Management's IVERIC bio position peaked at $4.83M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2023.

Based on Anson Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.